Brenda Schmidt, MS, MBS, moderates a discussion on the diabetes online community and the opportunity for social media in type 1 and type 2 diabetes care. She is joined by panelists Hope Warshaw, MMSc, RD, CDE, BC-ADM; Thomas C. Hawkins, MD, MS; Amy Tenderich, MA, and Kerri Sparling.
%jwplayer%
Brenda Schmidt, MS, MBS, moderates a discussion on the diabetes online community and the opportunity for social media in type 1 and type 2 diabetes care. She is joined by panelists Hope Warshaw, MMSc, RD, CDE, BC-ADM; Thomas C. Hawkins, MD, MS; Amy Tenderich, MA, and Kerri Sparling.
Amy Tenderich views social media as both a place for open communication as well as advocacy that allows the patient community to unite under a collective voice. She explains that online forums have become a critical method for patients to learn and better understand the disease from peers who share similar experiences.
Not only do these forums open communication lines from 1 patient to another, but it also provides a platform for patients to voice their opinions and thoughts to the pharmaceutical companies that develop the medications and devices for the patients, as well as to the FDA, payers, and various other stakeholders in order to better understand what it is that real patients want and need.
“People wanted to share their experiences in the real world, they wanted to ask each other questions about how they were titrating, dosing and about whatever effects they were experiencing, so there’s a great opportunity on the therapy side for people to learn from each other,” Tenderich said.
However, Warshaw believes that amongst the large patient population that exists in the Diabetes Care community, the engagement with these online forums is minimal. Sparling believes that the minimal representation of individuals diagnosed with type 2 diabetes mellitus may be due to the social stigma attached to the disease. The panelists discuss how patients can become more engaged with the diabetes care community, both online and in the real world.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen
2 Commerce Drive
Cranbury, NJ 08512